|
HY-32718-5mg
|
MedChemexpress LLC
|
Pelitinib [CAS 257933-82-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-32718-50mg
|
MedChemexpress LLC
|
Pelitinib [CAS 257933-82-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-32718-1mL
|
MedChemexpress LLC
|
Pelitinib [CAS 257933-82-7] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-103177-10mg
|
MedChemexpress LLC
|
PSB-10 (hydrochloride) [CAS 591771-91-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-103177-5mg
|
MedChemexpress LLC
|
PSB-10 (hydrochloride) [CAS 591771-91-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-101876-10mg
|
MedChemexpress LLC
|
Rhodamine 800 [CAS 137993-41-0]
|
|
|
|
|
HY-101876-25mg
|
MedChemexpress LLC
|
Rhodamine 800 [CAS 137993-41-0]
|
|
|
|
|
HY-D1716-1mg
|
MedChemexpress LLC
|
S0456 [CAS 1252007-83-2]
|
|
|
|
|
HY-D1716-10mg
|
MedChemexpress LLC
|
S0456 [CAS 1252007-83-2]
|
|
|
|
|
HY-D1716-5mg
|
MedChemexpress LLC
|
S0456 [CAS 1252007-83-2]
|
|
|
|
|
HY-Y0703-1g
|
MedChemexpress LLC
|
Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) [CAS 9004-32-4]
|
|
|
|
|
HY-Y0703-100mg
|
MedChemexpress LLC
|
Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) [CAS 9004-32-4]
|
|
|
|
|
HY-Y0703-500mg
|
MedChemexpress LLC
|
Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) [CAS 9004-32-4]
|
|
|
|
|
HY-101454-10mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-100mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-25mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-5mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-50mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-1mL
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-141716-10mg
|
MedChemexpress LLC
|
SW2_110A
|
|
Cancer-programmed cell death
|
|
|
HY-141716-100mg
|
MedChemexpress LLC
|
SW2_110A
|
|
Cancer-programmed cell death
|
|
|
HY-141716-25mg
|
MedChemexpress LLC
|
SW2_110A
|
|
Cancer-programmed cell death
|
|
|
HY-141716-5mg
|
MedChemexpress LLC
|
SW2_110A
|
|
Cancer-programmed cell death
|
|
|
HY-141716-50mg
|
MedChemexpress LLC
|
SW2_110A
|
|
Cancer-programmed cell death
|
|
|
HY-107615-10mg
|
MedChemexpress LLC
|
TC LPA5 4 [CAS 1393814-38-4]
|
|
Cancer-programmed cell death
|
|
